Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross‐sectional, multicentre study of 263 patients
Clinical and Experimental Dermatology2021Vol. 47(1), pp. 63–71
Citations Over TimeTop 10% of 2021 papers
Sezgi Sarıkaya Solak, Asude Kara Polat, S. Kilic, İlteriş Oğuz Topal, Hayriye Sarıcaoğlu, Ayşe Serap Karadağ, Filiz Canpolat, Selda Pelin Kartal, Beyza Nur Deveci, Nida Kaçar, Algün Polat Ekinci, Rukiye Yasak Güner, Mualla Polat, Gürsoy Doğan, Müge Güler Özden, Emel Bülbül Başkan, Göknur Özaydın Yavuz, Esra Adışen, Ayla Gülekon, M. E. Tanribilir, Oğuz Yılmaz, Ayşe Akman Karakaş, Perihan Öztürk, Didem Didar Balcı, Melis Gönülal, Haydar Yöndem, AT Ermertcan, Neslihan Şendur, Hilal Topyıldız, Selma Korkmaz, Erkan Alpsoy
Abstract
Our data suggest that smoking is a risk factor for both PPP development and disease severity. Patients with PPP with PsV present distinct clinical features and patients with biologic therapy-induced paradoxical PPP have reduced quality of life and are more likely to have PsA.
Related Papers
- → Etanercept for the treatment of psoriasis in the elderly(2006)53 cited
- → Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health‐related quality of life improvements and implications for treatment goals(2019)38 cited
- → Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management(2018)37 cited
- The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis.(2017)
- Correlation Between Severity Index and Quality of Life Index in Patients With Psoriasis Assessed Before and After Phototherapy.(2018)